Dongjun Jeong
Overview
Explore the profile of Dongjun Jeong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Kim H, Hong I, Lee M, Kim H, Kwak H, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076494
Globally, the mortality rate of colorectal cancer (CRC) remains high. Despite the development of various treatments, such as targeted therapy and immunotherapy, colorectal cancer continues to be a serious health...
2.
Hong I, Kim S, Lee M, Han S, Kim H, Chu C, et al.
Curr Oncol
. 2025 Feb;
32(2).
PMID: 39996914
Colorectal cancer (CRC) is a commonly fatal cancer and ranks as the fourth most prevalent in men and third in women worldwide. While early-stage survival rates are high, they significantly...
3.
Lee H, Shim W, Jeong D, Kwon Y, Youn S
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373744
Predicting the unseen arterial course and branching pattern distal to vessel occlusion is crucial for endovascular thrombectomy in acute stroke patients. We investigated whether a comprehensive interpretation of NCT and...
4.
Roh S, Kim S, Hong I, Lee M, Kim H, Ahn T, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047447
Cancer is a major disease and the leading cause of death worldwide, with colorectal cancer (CRC) being the third-most common cancer in Korea. The survival rate associated with CRC reduces...
5.
Kim H, Hong I, Roh S, Kim S, Kim H, Oh S, et al.
Oncol Rep
. 2023 Mar;
49(4).
PMID: 36866762
Colorectal cancer (CRC) is common cancer worldwide, and the 5‑year relative survival rate of CRC patients with distant metastasis is as low as 14%. Therefore, identifying markers of CRC is...
6.
Kim S, Kim D, Roh S, Hong I, Kim H, Ahn T, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327428
Uncovering tumor markers of colorectal cancer is important for the early detection and prognosis of the patients. Spermine oxidase (SMOX) is upregulated in various cancers. The present study aims to...
7.
Singh T, Kang D, Kim T, Kong H, Ryu J, Jeon S, et al.
Int J Pharm
. 2021 Jul;
606:120904.
PMID: 34293467
Pt-based drugs are one of the main active agents in colorectal cancer treatment. However, drug resistance and dose-dependent side effects are the main barriers that restrict their clinical applications. As...
8.
Kang D, Woo J, Kim H, Kim S, Ji S, Jaygal G, et al.
Int J Mol Sci
. 2020 Oct;
21(21).
PMID: 33114545
HJURP is a key factor for CENP-A deposition and maintenance in centromeres. The role of mis-regulation of histone chaperones in cancer initiation and progression has been studied. However, its role...
9.
Kim H, Kim T, Jaygal G, Woo J, Kim C, Baek M, et al.
Pathol Res Pract
. 2020 Jul;
216(8):153044.
PMID: 32703504
Introduction: microRNAs (miRNAs) are frequently dysregulated in many human cancers including colorectal cancer (CRC) and are useful candidate biomarkers in liquid biopsy of cancer for their stability in the blood....
10.
Lee J, Kim E, Lee J, Kim D, Kim H, Kim C, et al.
Cancer Cell Int
. 2020 Feb;
20:42.
PMID: 32042269
Background: Although major driver gene mutations have been identified, the complex molecular heterogeneity of colorectal cancer (CRC) remains unclear. Capicua (CIC) functions as a tumor suppressor in various types of...